Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity

Clinical trial NCT05033106 · UNKNOWN

Trial details

NCT number: NCT05033106
Sponsor: Zagazig University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Retinopathy of Prematurity Both Eyes

Start date: 2020-09-01
Primary completion: 2022-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.